期刊文献+

药师主导管理模式对非瓣膜性房颤住院患者华法林标准化抗凝治疗效果的影响 被引量:1

Study on standardized warfarin anticoagulation in hospitalized patients with nonvalvular atrial fibrillation under the mode of pharmacist-led management
下载PDF
导出
摘要 目的分析药师主导管理模式对非瓣膜性房颤住院患者华法林标准化抗凝治疗效果的影响。方法选取某院2020年1月~2021年6月采用华法林标准化抗凝治疗的非瓣膜性房颤住院患者105例,随机分为对照组(n=49)和观察组(n=56)。两组均采用华法林标准化抗凝治疗,对照组由临床医师主导抗凝管理,观察组由临床药师主导抗凝管理并提供全面健康教育。比较两组患者在治疗后的服药依从性、INR达标率及抗凝知识知晓程度。结果治疗后,观察组的服药依从性和INR达标率均高于对照组(P<0.05);对于抗凝知识的掌握程度,观察组优于对照组(P<0.05)。结论药师主导管理模式对非瓣膜性房颤住院患者华法林标准化抗凝治疗效果有积极促进作用,提高了患者的服药依从性和INR达标率,增加了治疗的有效性和安全性。 Objective To analyze the effect of pharmacist-led management on standardized warfarin anticoagulation in hospitalized patients with nonvalvular atrial fibrillation.Methods From January 2020 to June 2021,the standardization of warfarin anticoagulation therapy for 105 inpatients with non-valvular atrial fibrillationin in our hospital were selected,whom were randomly divided into control group(n=49)and observation group(n=56).Both groups received standardized warfarin anticoagulation therapy.The anticoagulant management was led by clinicians in the control group,while the observation group was led by clinical pharmacists and provided comprehensive health education.After treatment,medication compliance,INR compliance rate and knowledge of anticoagulation were compared between the two groups.Results After treatment,the medication compliance and INR compliance rate of the observation group were higher than those of the control group(P<0.05),and knowledge of anticoagulation of the observation group was better than that of the control group(P<0.05).Conclusion The mode of pharmacist-led management can positively promote the effect of standardized warfarin anticoagulation in hospitalized patients with nonvalvular atrial fibrillation,improve the treatment compliance and INR compliance rate,and increase the effectiveness and safety of medication.
作者 伏星驰 FU Xing-chi(Department of Pharmacy,Taizhou Hospital of Traditional Chinese and Western Medicine,Taizhou 225300,China)
出处 《中国处方药》 2022年第11期68-70,共3页 Journal of China Prescription Drug
关键词 非瓣膜性房颤 华法林标准化抗凝 药师主导 Nonvalvular atrial fibrillation Standardized Warfarin anticoagulation Pharmacist-led
  • 相关文献

参考文献13

二级参考文献105

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494.
  • 2胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量:162
  • 3心房颤动抗栓研究协作组,胡大一,孙艺红,张鹤萍,姜立清.华法林对非瓣膜病心房颤动抗栓的安全性和有效性研究[J].中华内科杂志,2006,45(10):800-803. 被引量:64
  • 4郑策,梅丹.影响华法林抗凝血作用的有关因素[J].药物不良反应杂志,2007,9(4):256-261. 被引量:102
  • 5Hirsh J, Fuster V, Ansell J, et al. American Heart Association/ American College of Cardiology Foundation guide to warfarin therapy. J Am Coil Cardiol, 2003,41:1633-1652.
  • 6Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med, 2007, 146:S57-867.
  • 7Hu D, Sun Y. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. J Am Coil Cardiol, 2008, 52: 865-868.
  • 8Rieder MJ, Reiner AP, Gage BF, et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med, 2005,352:2285-2293.
  • 9Aithal GP, Day CP, Kesteven PJ, et al. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet, 1999, 353:717-719.
  • 10Ageno W, Gallus AS, Wittkowsky A, et al. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012, 141 (2 Suppl) :eddS- 88S.

共引文献663

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部